The Biden administration on Friday rescinded a Trump-era rule that would have given medical device companies faster Medicare payments for life-saving products.
The Centers for Medicare & Medicare Services said in a statement it was taking the action “because of concerns that the provisions in the final rule may not have been sufficient to protect Medicare patients.”
“Although we continue to be in favor of enhancing access to new technologies, we are mindful that they may have unknown or unexpected risks and must first ensure such technologies improve health outcomes for Medicare beneficiaries,” CMS Administrator Chiquita Brooks-LaSure said. “The Medicare ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.